Federal award (DELIVERY ORDER, fiscal year 2023)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2024-01-31 to 2024-02-12
Current total value of award: $79.33
Description: 8510417314!MIDAZOLAM HYDROCHLO